November 5, 2008
ICON Medical Imaging to participate at the American Heart Association 2008 Scientific Sessions
ICON Medical Imaging is delighted to announce that it is a participating institution in 2 presentations at the Annual Scientific Session of the American Heart Association, in New Orleans, November 9 - 12, 2008.
"The Selective Cardiac Myosin Activator, CK-1827452, Increases Systolic Function in a Concentration-Dependent Manner in Patients with Stable Heart Failure" will be presented in a Cardiovascular Seminar (#117) entitled "Translational Trials and Strategies: First in Man" on Sunday, November 9, 2008, from 5:15 PM - 6:45 PM Central in Rooms 275-277 of Ernest N. Morial Convention Center. The presentation will be made by John Cleland, MD, FACC, FRCP, FESC, Professor of Cardiology, Castle Hill Hospital, University of Hull, United Kingdom.
“Iodofiltic Acid I 123 SPECT Provides Incremental Diagnostic Value over Initial Clinical Information in Emergency Department Patients with Suspected Acute Coronary Syndrome” will be presented in a poster session on Sunday November 9 from 9:30 am to 11:00 am. The poster will be presented by Dr. Michael Kontos, MD FACC, of Virginia Commonwealth University, Richmond, Virginia.
The Chief Medical Officer of ICON Medical Imaging, Jonathan Goldman MD FACC is a co-author on both presentations.
October 2008
September 2008
ICON Medical Imaging Completes Another Successful FDA Audit
ICON Medical Imaging reports the successful completion of another FDA audit that ended with no 483s issues nor any deficiencies noted. Read more >>
September 1, 2008
The abstract is entitled "First clinical trial of the selective cardiac myosin activator, CK-1827452, in heart failure: effect of dose and plasma concentration on systolic function".
August 11, 2008
ICON Medical Imaging Announces Novel Angiographic Intrepretation Software
July 2008
ICON Medical Imaging offers an Electronic Adjudication Solution
June 2008
April 2008
ICON Medical Imaging featured as the SPECT imaging core lab in European Heart Journal
The article, entitled "MR-IMPACT: comparison of perfusion-cardiac magnetic response with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial" highlights Beacon Bioscience as the SPECT imaging core lab used in the trial. This reference can be found on page 483 of the article.
December 2007
Review of the DIA - FDA Medical Imaging Stakeholders Call for Action meeting
Review the article written by Andrew F. Kraus, IMI's CTO & Executive Vice President in the December issue of DIA Today.
November 2007
"Thinking Outside the "Box" The Ultrasound Contrast Controversy" Journal of the American College of Cardiology
Review the article written by Dr. Jonathan Goldman's, IMI's CMO, as it appeared in the November 2007 issue.
November 9 , 2007
ICON Medical Imaging Recruits Chief Medical Officer
October 29, 2007
Commercial Imaging Corelab Pioneer Joins ICON Medical Imaging
March 12, 2007
Beacon Bioscience Unveils a New Name and New Offices